Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
about
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesPharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.
P2860
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
@en
type
label
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
@en
prefLabel
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
@en
P2093
P2860
P1476
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
@en
P2093
Frank LoVecchio
Phillip D Levy
William Frank Peacock
Zubaid Rafique
P2860
P304
P356
10.1517/14656566.2015.1066334
P407
P577
2015-08-01T00:00:00Z